PHOTON DYNAMICS INC
DEF 14A, 1997-12-31
SPECIAL INDUSTRY MACHINERY, NEC
Previous: DOANE PRODUCTS CO, S-4, 1997-12-31
Next: JUNDT FUNDS INC, 497, 1997-12-31



<PAGE>
 
                           SCHEDULE 14A INFORMATION
 
                 PROXY STATEMENT PURSUANT TO SECTION 14(a) OF
                      THE SECURITIES EXCHANGE ACT OF 1934
 
Filed by the Registrant [X]
 
Filed by a Party other than the Registrant [_]
 
Check the appropriate box:
 
[_] Preliminary Proxy Statement
 
[_] Confidential, for Use of the Commission Only (as permitted by Rule 
    14a-6(e)(2))
 
[X] Definitive Proxy Statement
 
[_] Definitive Additional Materials
 
[_] Soliciting Material Pursuant to (S) 240.14a-11(c) or (S) 240.14a-12
 
                             PHOTON DYNAMICS, INC.
               (NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
 
   ------------------------------------------------------------------------- 
    (Name of Person(s) Filing Proxy Statement if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box)
 
[X] No fee required.
 
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
 
  1. Title of each class of securities to which transaction applies:
- -------------------------------------------------------------------------------
 
  2. Aggregate number of securities to which transaction applies:
- -------------------------------------------------------------------------------
 
  3. Per unit price or other underlying value of transaction computed
     pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
     filing fee is calculated and state how it was determined):
- -------------------------------------------------------------------------------
 
  4. Proposed maximum aggregate value of transaction:
- -------------------------------------------------------------------------------
 
  5. Total fee paid:
- -------------------------------------------------------------------------------
 
[_] Fee paid previously with preliminary materials.
 
[_] Check box if any part of the fee is offset as provided by Exchange Act
    Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
    paid previously. Identify the previous filing by registration statement
    number, or the Form or Schedule and the date of its filing.
 
  1) Amount Previously Paid:
- -------------------------------------------------------------------------------
 
  2) Form, Schedule or Registration Statement No.:
- -------------------------------------------------------------------------------
 
  3) Filing Party:
- -------------------------------------------------------------------------------
 
  4) Date Filed:
- -------------------------------------------------------------------------------
<PAGE>
 
                             PHOTON DYNAMICS, INC.
                            6325 San Ignacio Avenue
                          San Jose, California 95119
 
                   NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
                        TO BE HELD ON JANUARY 27, 1998
 
TO THE SHAREHOLDERS OF PHOTON DYNAMICS, INC.:
 
  NOTICE IS HEREBY GIVEN that the Annual Meeting of Shareholders of PHOTON
DYNAMICS, INC., a California corporation (the "Company"), will be held on
Tuesday, January 27, 1998 at 2:00 p.m. local time at the Company's principal
executive offices, 6325 San Ignacio Avenue, San Jose, California 95119 for the
following purposes.
 
  1. To elect directors to serve for the ensuing year and until their
     successors are elected.
 
  2. To approve the Company's 1995 Stock Option Plan, as amended, to increase
     the aggregate number of shares of Common Stock authorized for issuance
     under such plan by 300,000 shares.
 
  3. To approve the Company's 1995 Employee Stock Purchase Plan, as amended,
     to increase the aggregate number of shares of Common Stock authorized
     for issuance under such plan by 100,000 shares.
 
  4. To ratify the selection of Ernst & Young LLP as independent auditors of
     the Company for its fiscal year ending September 30, 1998.
 
  5. To transact such other business as may properly come before the meeting
     or any adjournment or postponement thereof.
 
  The foregoing items of business are more fully described in the Proxy
Statement accompanying this Notice.
 
  The Board of Directors has fixed the close of business on December 19, 1997,
as the record date for the determination of shareholders entitled to notice of
and to vote at this Annual Meeting and at any adjournment or postponement
thereof.
 
                                          By Order of the Board of Directors
 
                                          /s/ Howard M. Bailey

                                          Howard M. Bailey
                                          Chief Financial Officer
 
San Jose, California
December 31, 1997
 
  ALL SHAREHOLDERS ARE CORDIALLY INVITED TO ATTEND THE MEETING IN PERSON.
WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING, PLEASE COMPLETE, DATE, SIGN
AND RETURN THE ENCLOSED PROXY AS PROMPTLY AS POSSIBLE IN ORDER TO ENSURE YOUR
REPRESENTATION AT THE MEETING. A RETURN ENVELOPE (WHICH IS POSTAGE PREPAID IF
MAILED IN THE UNITED STATES) IS ENCLOSED FOR THAT PURPOSE. EVEN IF YOU HAVE
GIVEN YOUR PROXY, YOU MAY STILL VOTE IN PERSON IF YOU ATTEND THE MEETING.
PLEASE NOTE, HOWEVER, THAT IF YOUR SHARES ARE HELD OF RECORD BY A BROKER, BANK
OR OTHER NOMINEE AND YOU WISH TO VOTE AT THE MEETING, YOU MUST OBTAIN FROM THE
RECORD HOLDER A PROXY ISSUED IN YOUR NAME.
<PAGE>
 
                             PHOTON DYNAMICS, INC.
                            6325 San Ignacio Avenue
                          San Jose, California 95119
 
                                PROXY STATEMENT
                      FOR ANNUAL MEETING OF SHAREHOLDERS
 
                               JANUARY 27, 1998
 
                INFORMATION CONCERNING SOLICITATION AND VOTING
 
GENERAL
 
  The enclosed proxy is solicited on behalf of the Board of Directors of
Photon Dynamics, Inc., a California corporation (the "Company"), for use at
the Annual Meeting of Shareholders to be held on January 27, 1998, at 2:00
p.m. local time (the "Annual Meeting"), or at any adjournment or postponement
thereof, for the purposes set forth herein and in the accompanying Notice of
Annual Meeting. The Annual Meeting will be held at the Company's principal
executive offices, 6325 San Ignacio Avenue, San Jose, California 95119. The
Company intends to mail this proxy statement and accompanying proxy card on or
about December 31, 1997, to all shareholders entitled to vote at the Annual
Meeting.
 
SOLICITATION
 
  The Company will bear the entire cost of solicitation of proxies, including
preparation, assembly, printing and mailing of this proxy statement, the proxy
and any additional information furnished to shareholders. Copies of
solicitation materials will be furnished to banks, brokerage houses,
fiduciaries and custodians holding in their names shares of Common Stock
beneficially owned by others to forward to such beneficial owners. The Company
may reimburse persons representing beneficial owners of Common Stock for their
costs of forwarding solicitation materials to such beneficial owners. Original
solicitation of proxies by mail may be supplemented by telephone, telegram or
personal solicitation by directors, officers or other regular employees of the
Company, or, at the Company's request, Beacon Hill Partners, Inc. No
additional compensation will be paid to directors, officers or other regular
employees for such services, but Beacon Hill Partners, Inc. will be paid its
customary fee, estimated to be approximately $4,000, if it renders
solicitation services.
 
VOTING RIGHTS AND OUTSTANDING SHARES
 
  Only holders of record of Common Stock at the close of business on December
19, 1997 will be entitled to notice of and to vote at the Annual Meeting. At
the close of business on December 19, 1997 the Company had 128 shareholders of
record and outstanding and entitled to vote 7,157,177 shares of Common Stock.
 
  Each holder of record of Common Stock on such date will be entitled to one
vote for each share held on all matters to be voted upon. With respect to the
election of directors, shareholders may exercise cumulative voting rights.
Under cumulative voting, each holder of Common Stock will be entitled to seven
(7) votes for each share held. Each shareholder may give one candidate, who
has been nominated prior to voting, all the votes such shareholder is entitled
to cast or may distribute such votes among as many such candidates as such
shareholder chooses. However, no shareholder will be entitled to cumulate
votes unless the candidate's name has been placed in nomination prior to the
voting and at least one shareholder has given notice at the meeting, prior to
the voting, of his or her intention to cumulate votes. Unless the proxyholders
are otherwise instructed, shareholders, by means of the accompanying proxy,
will grant the proxyholders discretionary authority to cumulate votes.
 
  All votes will be tabulated by the inspector of election appointed for the
meeting, who will separately tabulate affirmative and negative votes,
abstentions and broker non-votes. Abstentions and broker non-votes are counted
towards a quorum but are not counted for any purpose in determining whether a
matter is approved.
<PAGE>
 
REVOCABILITY OF PROXIES
 
  Any person giving a proxy pursuant to this solicitation has the power to
revoke it at any time before it is voted. It may be revoked by filing with the
Secretary of the Company at the Company's principal executive office, 6325 San
Ignacio Avenue, San Jose, California 95119, a written notice of revocation or
a duly executed proxy bearing a later date, or it may be revoked by attending
the meeting and voting in person. Attendance at the meeting will not, by
itself, revoke a proxy.
 
SHAREHOLDER PROPOSALS
 
  Proposals of shareholders that are intended to be presented at the Company's
1999 Annual Meeting of Shareholders must be received by the Company not later
than August 30, 1998 in order to be included in the proxy statement and proxy
relating to that Annual Meeting.
 
                                  PROPOSAL 1
 
                             ELECTION OF DIRECTORS
 
  There are seven nominees, with two vacancies remaining, for the nine Board
positions presently authorized in the Company's Bylaws. The Company has chosen
to nominate only seven directors at this time and may, in the future, consider
additional candidates but currently does not intend to appoint additional
members to the Board. Each director to be elected will hold office until the
next annual meeting of shareholders and until his successor is elected and has
qualified, or until such director's earlier death, resignation or removal.
Each nominee listed below is currently a director of the Company, each having
been elected by the shareholders: Vincent Sollitto, Jr., Francois J. Henley,
E. Floyd Kvamme, Barry L. Cox, Michael J. Kim, Steven M. Krausz and Malcolm J.
Thompson.
 
  Shares represented by executed proxies will be voted, if authority to do so
is not withheld, for the election of the seven nominees named below, subject
to the discretionary power to cumulate votes. Proxies cannot be voted for a
greater number of persons than the number of nominees named. In the event that
any nominee should be unavailable for election as a result of an unexpected
occurrence, such shares will be voted for the election of such substitute
nominee as management may propose. Each person nominated for election has
agreed to serve if elected and management has no reason to believe that any
nominee will be unable to serve.
 
  The seven candidates receiving the highest number of affirmative votes cast
at the meeting will be elected directors of the Company.
 
                       THE BOARD OF DIRECTORS RECOMMENDS
                    A VOTE IN FAVOR OF EACH NAMED NOMINEE.
 
NOMINEES
 
  The names of the nominees and certain information about them are set forth
below:
 
<TABLE>
<CAPTION>
                                                 PRINCIPAL OCCUPATION/
            NAME             AGE            POSITION HELD WITH THE COMPANY
            ----             ---            ------------------------------
 <C>                         <C> <S>
 Mr. Vincent Sollitto, Jr... 49  Chief Executive Officer
 Mr. Francois J. Henley..... 38  Chief Executive Officer of Silicon Genesis
                                 Corporation
 Mr. E. Floyd Kvamme........ 60  Chairman of the Board and General Partner of Kleiner
                                 Perkins Caufield & Byers, a venture capital
                                 partnership
 Mr. Barry L. Cox........... 55  Private investor
 Mr. Michael J. Kim......... 52  Executive Director of the San Jose Information and
                                 Investment Center at LG Electronics Inc.
 Mr. Steven M. Krausz....... 43  Partner at U.S. Venture Partners, a venture capital
                                 partnership
 Dr. Malcolm J. Thompson.... 52  President and Chief Executive Officer of dpiX,
                                 Incorporated
</TABLE>
 
                                       2
<PAGE>
 
  Mr. Sollitto joined the Company as Chief Executive Officer in June 1996 and
became a member of the Board of Directors of the Company in July 1996. From
August 1993 to 1996, Mr. Sollitto was the General Manager of Business Unit
Operations for Fujitsu Microelectronics, Inc. From April 1991 to August 1993,
he was the Executive Vice President of Technical Operations at Supercomputer
Systems, Incorporated. Mr. Sollitto spent 21 years in various positions,
including Director of Technology and Process at International Business
Machines Corporation, before joining Supercomputer Systems, Incorporated. Mr.
Sollitto serves as a director of Irvine Sensors Corp. and Chronamotion
Imaging, Inc. Mr. Sollitto is a graduate of Tufts College where he received a
B.S.E.E. in 1970.
 
  Mr. Henley founded the Company in 1986 and has been a member of the Board of
Directors since that time. He has been Chief Executive Officer of Silicon
Genesis Corporation since June 1997. From July 1994 to July 1997, Mr. Henley
was Chief Technical Officer of the Company and from June 1986 to June 1994, he
held various other positions in the Company, including that of President.
Prior to 1986, Mr. Henley held various engineering positions at Hewlett-
Packard Company, Intel Corporation and Spectrum Sciences, Inc. Mr. Henley
received a B.S.E.E. from Rensselaer Polytechnic Institute in 1980 and an
M.S.E.E. from the University of California, Berkeley in 1982, where he
completed Ph.D. course requirements in quantum electronics.
 
  Mr. Kvamme has been a member of the Board of Directors since 1986. He has
been a general partner of Kleiner Perkins Caufield & Byers since March 1984.
Mr. Kvamme also serves on the Boards of Directors of Harmonic Lightwaves,
Inc., TriQuint Semiconductor, Inc., Prism Solutions, Inc. and several
privately held companies. Mr. Kvamme received a B.S.E.E. from the University
of California, Berkeley and an M.S.E. from Syracuse University.
 
  Mr. Cox has been a member of the Board of Directors since 1990 and is
currently a consultant and private investor. Mr. Cox served as the President,
Chief Operating Officer and a director of Weitek Corporation from 1992 to 1993
and served as its President and Chief Executive Officer from 1993 to 1995. Mr.
Cox was a founder and director of ATEQ Corporation, a semiconductor capital
equipment manufacturer, and from 1987 to 1992 served as its President and
Chief Executive Officer. Mr. Cox received a B.S. in engineering from the U.S.
Air Force Academy and an M.B.A. from Boston University.
 
  Mr. Kim has been a member of the Board of Directors since 1991. He currently
serves as Executive Director of the San Jose Information and Investment Center
at LG Electronics Inc., and served as Executive Director of new business
development at LG Electronics Inc. from 1992 to 1997. From February 1988 to
June 1992, Mr. Kim served as a Vice President at Goldstar Technology, Inc.,
formerly a subsidiary of LG Electronics Inc. Mr. Kim received a B.S.E.E. from
the University of Illinois, Chicago and an M.S.E.E. from the University of
Santa Clara.
 
  Mr. Krausz has been a member of the Board of Directors since 1994. He has
been a partner at U.S. Venture Partners since 1985. Mr. Krausz also serves on
the Boards of Directors of Verity, Inc. and several privately held companies.
He received a B.S.E.E. from Stanford University and an M.B.A. from the
Stanford University Graduate School of Business.
 
  Dr. Thompson has been a member of the Board of Directors since 1992. He is
the President and Chief Executive Officer of dpiX, Incorporated and the
founder and Chairman of the U.S. Display Consortium. He was the Chief
Technologist at Xerox Corporation from 1981 to 1996. Dr. Thompson received a
B.S. and a Ph.D. from Brighton Polytechnic.
 
BOARD COMMITTEES AND MEETINGS
 
  During the fiscal year ended September 30, 1997, the Board of Directors held
nine meetings. The Board has an Audit Committee and a Compensation Committee.
 
  The Audit Committee meets with the Company's independent auditors at least
annually to review the results of the annual audit and discuss the financial
statements, recommends to the Board the independent auditors to be
 
                                       3
<PAGE>
 
retained and receives and considers the accountants' comments as to controls,
adequacy of staff and management performance and procedures in connection with
audit and financial controls. The Audit Committee is composed of three non-
employee directors: Messrs. Kvamme, Thompson and Kim. It met one time during
such fiscal year.
 
  The Compensation Committee makes recommendations concerning salaries and
incentive compensation, awards stock options to employees and consultants
under the Company's stock option plans and otherwise determines compensation
levels and performs such other functions regarding compensation as the Board
may delegate. The Compensation Committee is composed of three non-employee
directors: Messrs. Kvamme, Cox and Krausz. It met one time during such fiscal
year.
 
  During the fiscal year ended September 30, 1997, all directors except
Francois J. Henley and Malcolm J. Thompson attended 75% or more of the
aggregate of the meetings of the Board and of the committees on which they
served, held during the period for which they were a director or committee
member, respectively.
 
                                  PROPOSAL 2
 
              APPROVAL OF THE 1995 STOCK OPTION PLAN, AS AMENDED
 
  In March 1995, the Board of Directors adopted, and the shareholders
subsequently approved, the Company's 1995 Stock Option Plan (the "Option
Plan"). The Option Plan was amended from time to time thereafter. There are
currently 810,943 shares of the Company's Common Stock authorized for issuance
under the Option Plan.
 
  At September 30, 1997, options (net of canceled or expired options)
outstanding and exercisable or previously exercised covering an aggregate of
792,184 shares of the Company's Common Stock had been granted under the Option
Plan, and only 170,653 shares (plus any shares that might in the future be
returned to the plan as a result of cancellations or expiration of options)
remained available for future grant under the Option Plan.
 
  In December 1997, the Board approved an amendment to the Option Plan,
subject to shareholder approval, to increase the number of shares authorized
for issuance under the Option Plan from a total of eight hundred ten thousand
nine hundred forty-three (810,943) shares to one million one hundred ten
thousand nine hundred forty-three (1,110,943) shares. The Board adopted this
amendment to ensure that the Company can continue to grant stock options to
employees at levels determined appropriate by the Board.
 
  Vote Required. Shareholders are requested in this Proposal 2 to approve the
Option Plan, as amended. The affirmative vote of the holders of a majority of
the shares present in person or represented by proxy and voting at the meeting
will be required to approve the Option Plan, as amended. For purposes of this
vote, abstentions and broker non-votes will not be counted for any purpose in
determining whether this matter has been approved.
 
                       THE BOARD OF DIRECTORS RECOMMENDS
                        A VOTE IN FAVOR OF PROPOSAL 2.
 
  The essential features of the Option Plan are outlined below.
 
GENERAL
 
  The Option Plan provides for the grant of both incentive and nonstatutory
stock options to employees, officers, directors, independent contractors, and
consultants of the Company and its affiliates.
 
  Incentive stock options granted under the Option Plan are intended to
qualify as "incentive stock options" within the meaning of Section 422 of the
Internal Revenue Code of 1986, as amended (the "Code"). Nonstatutory stock
options granted under the Option Plan are intended not to qualify as incentive
stock options
 
                                       4
<PAGE>
 
under the Code. See "Federal Income Tax Information" for a discussion of the
tax treatment of incentive and nonstatutory stock options.
 
PURPOSE
 
  The Option Plan was adopted to give the employees, officers, directors,
independent contractors, and consultants to the Company and its affiliates
incentive, through ownership of the Company's Common Stock, to continue in
their service to the Company and to help the Company compete effectively with
other enterprises for the services of qualified individuals.
 
ADMINISTRATION
 
  The Board of Directors of the Company (the "Board"), or a committee (the
"Committee") composed of two or more members of the Board, is authorized to
administer the Option Plan. If administration is delegated to a Committee,
such Committee will have, in connection with the administration of the Option
Plan, the powers possessed by the Board. As used herein with respect to the
Option Plan, the "Board" refers to the Committee as well as the Board itself.
 
  Notwithstanding the foregoing, a subcommittee of the Committee composed
solely of two (2) or more "outside directors," as such term is defined under
Section 162(m) of the Code and the regulations thereunder (the
"Subcommittee"), shall make all grants of awards to eligible persons who are
"covered employees" as such term is defined in Section 162(m) of the Code.
References to the Committee include the Subcommittee.
 
  The Board has the power to construe and interpret the Option Plan and,
subject the provisions of the Option Plan, to determine the persons to whom
and the dates on which options will be granted, what type of option will be
granted, the number of shares to be subject to each option, the time or times
during the term of each option within which all or a portion of such option
may be exercised, the exercise price, the type of consideration and other
terms of the option.
 
SHARES SUBJECT TO THE OPTION PLAN
 
  Pursuant to the December 17, 1997 amendment, the Common Stock that may be
issued pursuant to awards under the Option Plan shall not exceed in the
aggregate one million one hundred ten thousand nine hundred forty-three
(1,110,943) shares of the Company's Common Stock. If any option is surrendered
(except surrender for shares of Common Stock) or for any other reason ceases
to be exercisable, in whole or in part, without having been exercised in full,
the stock not purchased under such option will revert to and again become
available for issuance under the Option Plan.
 
ELIGIBILITY
 
  Incentive stock options may be granted only to employees (including officers
and directors who are employees). Nonstatutory stock options may be granted to
employees, directors, officers, independent contractors, and consultants. All
of the Company's executive officers, employees, consultants and directors of
the Company are eligible to receive grants under the Option Plan. As of
December 17, 1997, the Company and its subsidiaries had approximately one
hundred twenty-five (125) executive officers, employees, consultants, and
directors. Non-Employee Directors are only eligible to receive the automatic,
non-discretionary stock options described below.
 
  No person is eligible for the grant of an incentive stock option, if at the
time of grant, such person owns stock possessing more than ten percent (10%)
of the total combined voting power of all classes of stock of the Company (a
"10% Shareholder") unless the exercise price of such option is at least one
hundred ten percent (110%) of the fair market value of such Common Stock
subject to the option at the date of grant and the option is not exercisable
after the expiration of five (5) years from the date of grant. The aggregate
fair market value,
 
                                       5
<PAGE>
 
determined at the time of grant, of the shares of Common Stock with respect to
which incentive stock options are exercisable for the first time during any
calendar year (under all such plans of the Company and its affiliates) may not
exceed one hundred thousand ($100,000) dollars. In addition, no person shall
be eligible to be granted options covering more than two hundred fifty
thousand (250,000) shares of the Company's Common Stock in any calendar year.
 
TERMS OF DISCRETIONARY OPTIONS
 
  Term. No discretionary option is exercisable after the expiration of ten
(10) years from the date it was granted.
 
  Exercise/Purchase Price. The exercise price of each discretionary option
will not be less than one hundred percent (100%) of the fair market value of
the Common Stock on the date of grant.
 
  Consideration. The purchase price of stock acquired pursuant to a
discretionary option is paid either: (a) in cash at the time the option is
exercised; or (b) at the discretion of the Committee, (i) by delivery of
already owned Common Stock of the Company or by withholding Common Stock
otherwise deliverable upon exercise of the discretionary option, (ii) by
delivery on a form prescribed by the Committee of an irrevocable direction to
a securities broker approved by the Committee to sell shares of stock and
deliver all or a portion of the proceeds to the Company in payment for the
stock, (iii) by delivery of the optionee's promissory note with such
provisions as the Committee determines appropriate, or (iv) any combination of
the foregoing (including cash).
 
  The Committee may, in its sole discretion, authorize the surrender of all or
part of an unexercised option (excluding non-discretionary options described
below) and authorize a payment thereof of an amount equal to the difference
between the fair market value of the Common Stock subject to such option and
the aggregate option price of such option. Such payment may be made in cash,
shares of Common Stock (using the fair market value on the date of surrender),
or some combination thereof.
 
  Transferability. An incentive stock option shall not be transferable except
by will or by the laws of descent and distribution, and shall be exercisable
during the lifetime of the person to whom the incentive stock option is
granted only by such person. A discretionary nonstatutory stock option shall
be transferable to the extent permitted by the option agreement covering the
option.
 
TERMS OF NON-DISCRETIONARY OPTIONS
 
  General. Each person who is elected for the first time to be a non-employee
director, and who is not an affiliate of a five percent (5%) shareholder (a
"Non-Employee Director"), will automatically, upon the date of his or her
initial election to be a Non-Employee Director, be granted a nonstatutory
stock option to purchase 5,000 shares of Common Stock (an "Initial Grant").
Immediately following each annual meeting of the Company's shareholders, each
Non-Employee Director shall be granted a nonstatutory stock option to purchase
an additional 2,500 shares of Common Stock, provided such Non-Employee
Director has provided services to the Company for at least one year (a
"Subsequent Grant").
 
  Term. No non-discretionary option is exercisable after the expiration of ten
(10) years from the date it was granted.
 
  Exercise/Purchase Price. The exercise price of each non-discretionary option
shall be one hundred percent (100%) of the fair market value of the Common
Stock on the date of grant.
 
  Consideration. The purchase price of stock acquired pursuant to a non-
discretionary option is paid either: (a) in cash at the time the non-
discretionary option is exercised; or (b) at the discretion of the Committee,
(i) by delivery of already owned Common Stock of the Company or by withholding
Common Stock otherwise deliverable upon exercise of the non-discretionary
option, or (ii) by delivery on a form prescribed by the
 
                                       6
<PAGE>
 
Committee of an irrevocable direction to a securities broker approved by the
Committee to sell shares of stock and deliver all or a portion of the proceeds
to the Company in payment for the stock, or (iii) any combination of the
foregoing (including cash).
 
  Transferability. Non-discretionary stock options granted to Non-Employee
Directors shall be transferable to the fullest extent permitted by Rule 16b-3
as so amended.
 
  Vesting. Each Initial Grant shall be fully vested and exercisable upon
receipt. Each Subsequent Grant shall vest and become exercisable in equal
monthly installments over a period of one year from the date of grant.
 
EFFECT OF CERTAIN CORPORATE EVENTS
 
  If any change is made in the Common Stock subject to the Option Plan, or
subject to any option granted under the Option Plan, without receipt of
consideration by the Company (through merger, consolidation, reorganization,
recapitalization, reincorporation, stock split, stock dividend (in excess of
two percent (2%)) or other change in the capital structure of the Company),
appropriate adjustments shall be made by the Committee in order to preserve
but not increase the benefits to the individual, including adjustments to the
number and kind of shares and the price per share subject to outstanding
options.
 
  A stock option agreement may provide for accelerated vesting in the event of
certain changes in control (all grants to Non-Employee Directors shall so
provide). If a stock option agreement contains a change in control provision,
it will also provide that the stock option will terminate upon the effective
date of change in control in which the Company is not the surviving entity, or
in which all or substantially all assets of the company are disposed of, sold
or transferred.
 
AMENDMENT OF PLAN AND GRANTS
 
  The Board at any time, and from time to time, may amend the Option Plan.
However, no amendment will be effective without the consent of shareholders
then sufficient to approve the Option Plan in the first instance where the
amendment will increase the maximum number of shares subject to stock options
issued under the Option Plan or change the designation or class of persons
eligible to receive incentive stock options under the Option Plan.
 
  Except for non-discretionary grants to Non-Employee Directors, the Board may
amend the terms of any outstanding option. However, any amendment which would
adversely affect the optionee's rights under an outstanding option shall not
be made without optionee's written consent. Notwithstanding the foregoing, the
Board may, without written consent, cancel any outstanding option or accept
any outstanding option in exchange for a new option.
 
TERMINATION OF PLAN
 
  The Board may suspend or terminate the Option Plan at any time. Unless
sooner terminated, the Option Plan will terminate on September 27, 2005.
 
FEDERAL INCOME TAX INFORMATION
 
  Incentive Stock Options. Options granted under the Option Plan which are
designated as incentive stock options are intended to be eligible for the
favorable federal income tax treatment accorded "incentive stock options"
under Section 422 of the Code.
 
  There generally are no federal income tax consequences to the optionee or
the Company by reason of the grant or exercise of an incentive stock option.
However, the exercise of an incentive stock option may increase the optionee's
alternative minimum tax liability, if any.
 
                                       7
<PAGE>
 
  If an optionee holds stock acquired through exercise of an incentive stock
option for at least two years from the date on which the option is granted and
at least one year from the date on which the shares are transferred to the
optionee upon exercise of the option, any gain or loss on a disposition of
such stock will be capital gain or loss. Generally, if the optionee disposes
of the stock before the expiration of either of these holding periods (a
"disqualifying disposition"), at the time of disposition, the optionee will
realize taxable ordinary income equal to the lesser of (a) the excess of the
stock's fair market value on the date of exercise over the exercise price, or
(b) the optionee's actual gain, if any, on the purchase and sale. The
optionee's additional gain, or any loss, upon the disqualifying disposition
will be a capital gain or loss. Any capital gain or loss recognized by an
optionee on a qualifying disposition or a disqualifying disposition of stock
acquired through exercise of an incentive stock option will be long-term, mid-
term, or short-term depending on how long the optionee holds the stock.
Slightly different rules may apply to optionees who acquire stock subject to
certain repurchase options or who are subject to Section 16 of the Exchange
Act.
 
  To the extent the optionee recognizes ordinary income by reason of a
disqualifying disposition, the Company will generally be entitled (subject to
the requirement of reasonableness, the provision of 162(m) of the Code, and
the satisfaction of a tax reporting obligation) to a corresponding business
expense deduction in the tax year in which the disqualifying disposition
occurs.
 
  Nonstatutory Stock Options. Options granted under the Option Plan which are
not designated as incentive stock options are "nonstatutory stock options"
which generally have the following federal income tax consequences:
 
  There are no tax consequences to the optionee or the Company by reason of
the grant of a nonstatutory stock option. Upon exercise of a nonstatutory
stock option, the optionee normally will recognize taxable ordinary income
equal to the excess of the stock's fair market value on the date of exercise
over the option exercise price. Generally, with respect to employees, the
Company is required to withhold from regular wages or supplemental wage
payments an amount based on the ordinary income recognized. Subject to the
requirement of reasonableness, the provisions of Section 162(m) of the Code,
and the satisfaction of a tax reporting obligation, the Company will generally
be entitled to a business expense deduction equal to the taxable ordinary
income realized by the optionee. Upon disposition of the stock, the optionee
will recognize a capital gain or loss equal to the difference between the
selling price and the sum of the amount paid for such stock plus any amount
recognized as ordinary income upon exercise of the option. Such gain or loss
will be long-term, mid-term or short-term depending on how long the optionee
holds the stock. Slightly different rules may apply to optionees who acquire
stock subject to certain repurchase options or who are subject to Section
16(b) of the Exchange Act.
 
  Potential Limitation on Company Deductions. Section 162(m) of the Code
denies a deduction to any publicly held corporation for compensation paid to
certain employees in a taxable year to the extent that compensation exceeds $1
million for a covered employee. It is possible that compensation attributable
to awards granted under the Option Plan, when combined with all other types of
compensation received by a covered employee from the Company, may cause this
limitation to be exceeded in any particular year.
 
  Certain kinds of compensation, including qualified "performance-based
compensation," are disregarded for purposes of the deduction limitation. In
accordance with Treasury regulations issued under Section 162(m) of the Code,
compensation attributable to stock options will qualify as performance-based
compensation, provided that: (i) the stock option plan contains a per-employee
limitation on the number of shares for which stock options may be granted
during a specified period; (ii) the per-employee limitation is approved by the
shareholders; (iii) the option is granted by a compensation committee
comprised solely of "outside directors;" and (iv) the exercise price of the
option is no less than the fair market value of the stock on the date of
grant. Stock options granted under the Plan are intended to qualify for
exemption for performance based compensation.
 
                                       8
<PAGE>
 
                                  PROPOSAL 3
 
           APPROVAL OF 1995 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED
 
  In September 1995, the Board of Directors (the "Board") adopted, and the
Shareholders subsequently approved, the Company's 1995 Employee Stock Purchase
Plan (the "Purchase Plan"), under which one hundred thousand (100,000) shares
of the Company's Common Stock were reserved for issuance. The Purchase Plan is
intended to qualify as an "employee stock purchase plan" under Section 423(b)
of the Code.
 
  At September 30, 1997, an aggregate of 65,040 shares of the Company's Common
Stock had been issued under the Purchase Plan, and only 34,960 shares remained
available for future grant under the Purchase Plan.
 
  In December 1997, the Board approved an amendment to the Purchase Plan,
subject to shareholder approval, to increase the number of shares authorized
for issuance under the Purchase Plan from a total of one hundred thousand
(100,000) shares to two hundred thousand (200,000) shares. The Board adopted
this amendment to ensure that the Company can continue to grant such
incentives to employees at levels determined appropriate by the Board.
 
  Vote Required. Shareholders are requested in this Proposal 3 to approve the
Purchase Plan, as amended. The affirmative vote of the holders of a majority
of the shares present in person or represented by proxy and voting at the
meeting will be required to approve the Purchase Plan, as amended. For
purposes of this vote, abstentions and broker non-votes will not be counted
for any purpose in determining whether this matter has been approved.
 
                       THE BOARD OF DIRECTORS RECOMMENDS
                        A VOTE IN FAVOR OF PROPOSAL 3.
 
  The essential features of the Purchase Plan are outlined below.
 
PURPOSE
 
  The Purchase Plan was adopted provide a means by which employees of the
Company (and any subsidiary of the Company designated by the Board to
participate in the Purchase Plan) may be given an opportunity to purchase
Common Stock of the Company through accumulated payroll deductions. The
Purchase Plan is intended to qualify as an "Employee Stock Purchase Plan" as
that term is defined in Section 423 of the Code.
 
ADMINISTRATION
 
  The Purchase Plan may be administered by the Board or by a committee of the
Board (the "Committee"). The Board has delegated for administration of the
Purchase Plan to the Committee. The Committee has, in connection with the
administration of the Purchase Plan, the powers possessed by the Board. As
used herein with respect to the Purchase Plan, the "Board" refers to such
Committee as well as to the Board itself.
 
  The Board has the power to construe, interpret and apply the terms of the
Purchase Plan, to determine eligibility and to adjudicate all disputed claims
filed under the plan in such a manner as shall comply with Rule 16b-3, as
amended.
 
PURCHASE PERIODS
 
  The Purchase Plan is implemented by a series of overlapping or consecutive
purchase periods (the "Purchase Period"). The maximum duration of any Purchase
Period shall be twenty-seven months. An accrual period is a period of
approximately six months, commencing on February 1 and August 1 of each year
and terminating the following July 31 or January 31, respectively (an "Accrual
Period").
 
                                       9
<PAGE>
 
  An employee who participates in the Purchase Plan is granted a separate
option to purchase shares of Common Stock for each Purchase Period in which he
or she participates. The option is granted on the first day of the Purchase
Period and is automatically exercised in successive installments on the last
day of each Accrual Period ending within the Purchase Period (the "Exercise
Date"). An employee may participate in only one Purchase Period at a time. In
the event that the fair market value of the Company's Common Stock is less
than the fair market value of the Company's Common Stock on the first day of
the first Accrual Period within the Purchase Period, the Purchase Period shall
be terminated and the employee shall be enrolled automatically in the new
Purchase Period that has its first Accrual Period commencing on that date,
provided the employee is eligible to participate in the Purchase Plan on that
date and has not elected to terminate participation in the Purchase Plan.
 
SHARES SUBJECT TO THE PLAN
 
  Pursuant to the December 17, 1997 amendment, the Common Stock that may be
sold pursuant to awards under the Purchase Plan shall not exceed in the
aggregate two hundred thousand (200,000) shares of the Company's Common Stock.
 
ELIGIBILITY
 
  Rights to purchase stock may be granted under the Purchase Plan only to
employees who are employed by the Company and whose customary employment is at
least twenty (20) hours per week and at least five (5) months per calendar
year.
 
  An eligible employee may be granted rights under the Purchase Plan only if
such rights, together with any other rights granted under all such employee
stock purchase plans of the Company or any affiliate do not permit such
employee's rights to purchase stock of the Company or any subsidiary to accrue
at a rate which exceeds $25,000 of the fair market value of such stock
(determined at the time such rights are granted) for each calendar year in
which such rights are outstanding at any time. No rights may be granted under
the Purchase Plan to any person who, immediately following such grant, would
own stock possessing 5% or more of the total combined voting power or value of
all classes of stock of the Company or of any subsidiary of the Company.
 
TERMS OF RIGHTS
 
  Rights; Purchase Price. On the first day of each Purchase Period, each
eligible employee participating in such Purchase Period shall be granted the
right to purchase up to the number of shares of Common Stock purchasable with
a percentage not exceeding 10% of such employee's earnings during each Accrual
Period in the Purchase Period. The maximum number of shares which may be
purchased by any employee in any Accrual Period shall be 5,000 shares. If on a
given Exercise Date the number of shares with respect to which options are to
be exercised exceeds the number of shares then available under the Purchase
Plan, the Company shall make a pro rata allocation of the shares remaining
available for purchase.
 
  The purchase price per share of Common Stock acquired pursuant to rights
granted under the Purchase Plan will not be less than the lesser of (i) 85% of
the fair market value of a share of Common Stock on the first day of the
Purchase Period or (ii) 85% of the fair market value of a share of Common
Stock on the Exercise Date.
 
  Transferability. Rights granted under the Purchase Plan are nontransferable
except by will or the laws of descent and distribution and may be exercised
only by the person to whom such rights are granted while that person is still
alive.
 
  Exercise. On each Exercise Date, a participant's accumulated payroll
deductions (without any increase for interest) will be applied to the purchase
of whole shares of Common Stock, up to the maximum number of shares permitted
pursuant to the terms of the Purchase Plan. No fractional shares will be
issued upon the exercise of rights granted under the Purchase Plan. Any
accumulated payroll earnings remaining in a participant's account
 
                                      10
<PAGE>
 
after the purchase of the number of whole shares purchasable in an amount less
than is required to purchase one whole share on the final Exercise Date will
be held in the participant's account for the purchase of shares on the next
Exercise Date under the Purchase Plan, unless the participant withdraws from
the Purchase Period or is no longer eligible to be granted rights under the
Purchase Plan, in which case such amount shall be distributed to the
participant after the final Exercise Date, without interest.
 
  Participation; Withdrawal; Termination. An eligible employee may become a
participate in a Purchase Period by delivering a subscription agreement to the
Company authorizing payroll deductions of up to 10% of such employee's
earnings during the Purchase Period to the Company's payroll office at least
fifteen (15) business days prior to the Enrollment Date or as specified by the
Board for such Purchase Period. Payroll deductions made for a participant
shall be credited to an account for such participant under the Purchase Plan.
A participant may (a) reduce payroll deductions during the Purchase Period, or
(b) increase payroll deductions for a future Purchase Period by filing a new
subscription agreement with the Company.
 
  A participant may withdraw all but not less than all the payroll deductions
credited to his/her account and not yet used to exercise his/her option under
the Purchase Plan at any time by giving written notice to the Company. All of
the participant's payroll deductions credited to his/her account will be paid
to such participant promptly after receipt of notice of withdrawal, such
participant's option for the Purchase Period will be automatically terminated,
and no further payroll deductions for the purchase of shares will be made
during the Purchase Period. If a participant withdraws from a Purchase Period,
payroll deductions will not resume at the beginning of the succeeding Purchase
Period unless the participant delivers to the Company a new subscription
agreement.
 
  Upon a participant's ceasing to be an employee for any reason or upon
termination of a participant's employment relationship, the payroll deductions
credited to such participant's account during the Purchase Period but not yet
used to exercise the option will be returned to such participant or, in the
case of his/her death, to the person or persons entitled thereto, and such
participant's option will be automatically terminated.
 
DURATION, AMENDMENT AND TERMINATION
 
  The Board may suspend or terminate the Purchase Plan at any time, provided
that except as described under "Certain Corporate Events," no such amendment
or termination can adversely affect options previously granted, provided that
a Purchase Period may be terminated by the Board on any Exercise Date if the
Board determines that the termination of the Plan is in the best interests of
the Company and its shareholders. To the extent necessary to comply with Rule
16b-3 or Section 423 of the Code (or any successor rule or provision or any
other applicable law or regulation), the Company shall obtain shareholder
approval in such a manner and to such a degree as required.
 
  Notwithstanding the foregoing, without shareholder consent and without
regard to whether any participant rights may be considered to have been
adversely affected, the Board shall be entitled to change the Purchase
Periods, limit the frequency and/or number of changes in the amount withheld
during Purchase Periods, establish the exchange ratio applicable to amounts
withheld in a currency other than U.S. dollars, permit payroll withholding in
excess of the amount designated by a participant in order to adjust for delays
or mistakes in the Company's processing of properly completed withholding
elections, establish reasonable waiting and adjustment periods and/or
accounting and crediting procedures to ensure that amounts applied toward the
purchase of Common Stock for each participant properly correspond with amounts
withheld from the participant's earnings, and establish such other limitations
or procedures as the Board determines in its sole discretion advisable which
are consistent with the Purchase Plan.
 
EFFECT OF CERTAIN CORPORATE EVENTS
 
  If there is any change in the stock subject to the Purchase Plan or subject
to any rights granted under the Purchase Plan (through stock split, reverse
stock split, stock dividend, combination or reclassification of the
 
                                      11
<PAGE>
 
Common Stock, or any other increase or decrease in the number of shares of
Common Stock effected without receipt of consideration by the Company (not
including conversions of convertible securities)), the Purchase Plan and
rights outstanding thereunder will be appropriately adjusted as to the class
and the maximum number of shares subject to such plan and the class, number of
shares and price per share of stock subject to such outstanding rights.
 
  In the event of a proposed sale of all or substantially all of the assets of
the Company, the merger of the Company with or into another corporation, in
which the Company will not be the surviving corporation (other than a
reorganization effectuated primarily to change the state in which the Company
is incorporated), or a reverse merger in which the Company is the surviving
corporation but in which securities possessing more than fifty percent (50%)
of the total combined voting power of the Company's outstanding securities are
transferred to a person or persons different from the person or persons
holding those securities immediately prior to the transfer, then any successor
corporation or parent or subsidiary of such successor corporation shall assume
such outstanding rights or substitute similar rights for those outstanding
under the Purchase Plan, unless the Board determines, in the exercise of its
sole discretion and in lieu of such assumption or substitution, to shorten the
Purchase Period then in progress by setting a new Exercise Date (the "New
Exercise Date").
 
FEDERAL INCOME TAX INFORMATION
 
  Participation in the Purchase Plan is intended to qualify for the favorable
federal tax treatment accorded "employee stock purchase plans" under Section
423 of the Code. Under these provisions, a participant will be taxed on
amounts withheld as if actually received, but, except for this, no income will
be taxable to a participant until disposition of the shares acquired.
 
  If the stock is disposed of at least two years after the beginning of the
Purchase Period and at least one year after the stock is transferred to the
participant, the lesser of (i) the excess of the fair market value of the
stock at the time of such disposition over the price paid for the stock or
(ii) the excess of the fair market value of the stock as of the beginning of
the Purchase Period over the purchase price (determined as of the beginning of
the Purchase Period) will be treated as ordinary income. Any further gain or
any loss will be taxed as a capital gain or loss.
 
  If the stock is sold or disposed of before the expiration of either of the
holding periods described above, the excess of the fair market value of the
stock on the Exercise Date over the purchase price paid will be treated as
ordinary income at the time of such disposition, and the Company may, in the
future, be required to withhold income taxes relating to such ordinary income
from other payments made to the participant. The balance of any gain will be
treated as capital gain.
 
  Any capital gain or loss recognized by a participant upon the disposition of
stock acquired under the Purchase Plan will be long-term, mid-term or short-
term, depending on how long the stock is held.
 
  There are no federal income tax consequences to the Company by reason of the
grant or exercise of rights under the Purchase Plan. The Company is entitled
to a deduction to the extent such amounts are taxed as ordinary income to a
participant upon disposition by a participant of stock before the expiration
of the holding periods described above (subject to the requirement of
reasonableness, the provisions of 162(m) of the Code, and, perhaps in the
future, satisfaction of a withholding obligation).
 
                                  PROPOSAL 4
 
               RATIFICATION OF SELECTION OF INDEPENDENT AUDITORS
 
  The Board of Directors has selected Ernst & Young LLP as the Company's
independent auditors for the fiscal year ending September 30, 1998, and has
further directed that management submit the selection of independent auditors
for ratification by the shareholders at the Annual Meeting. Ernst & Young LLP
has audited
 
                                      12
<PAGE>
 
the Company's financial statements since the year ended September 30, 1994.
Representatives of Ernst & Young LLP are expected to be present at the Annual
Meeting, will have an opportunity to make a statement if they so desire and
will be available to respond to appropriate questions.
 
  Shareholder ratification of the selection of Ernst & Young LLP as the
Company's independent auditors is not required by the Company's Bylaws or
otherwise. However, the Board is submitting the selection of Ernst & Young LLP
to the shareholders for ratification as a matter of good corporate practice.
If the shareholders fail to ratify the selection, the Audit Committee and the
Board of Directors will reconsider whether or not to retain that firm. Even if
the selection is ratified, the Audit Committee and the Board in their
discretion may direct the appointment of different independent auditors at any
time during the year if they determine that such a change would be in the best
interests of the Company and its shareholders.
 
  The affirmative vote of the holders of a majority of the shares present in
person or represented by proxy and voting at the Annual Meeting will be
required to ratify the selection of Ernst & Young LLP.
 
                       THE BOARD OF DIRECTORS RECOMMENDS
                        A VOTE IN FAVOR OF PROPOSAL 4.
 
                                      13
<PAGE>
 
                             SECURITY OWNERSHIP OF
                   CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
 
  The following table sets forth certain information regarding the ownership
of the Company's Common Stock as of November 30, 1997 by: (i) each director
and nominee for director; (ii) each of the executive officers named in the
Summary Compensation Table; (iii) all executive officers and directors of the
Company as a group; and (iv) all those known by the Company to be beneficial
owners of more than five percent (5%) of its Common Stock.
 
<TABLE>
<CAPTION>
                                                       BENEFICIAL OWNERSHIP(1)
                                                     --------------------------
                                                      NUMBER OF     PERCENT OF
    BENEFICIAL OWNER                                   SHARES         TOTAL
    ----------------                                 ------------- ------------
<S>                                                  <C>           <C>
E. Floyd Kvamme(2).................................        573,693        7.89%
LG Electronics Inc.(3).............................        562,708        7.83%
 3003 North First Street
 San Jose, CA 95134-2004
Michael J. Kim(3)..................................        562,708        7.83%
Kleiner Perkins Caufield & Byers IV(4).............        547,723        7.54%
 2750 Sandhill Road
 Menlo Park, CA 94025
ML Venture Partners II, L.P.(5)....................        431,297        6.02%
 3000 Sandhill Road
 Menlo Park, CA 94025
Francois J. Henley(6)..............................        297,779        4.14%
Steven M. Krausz(7)................................         87,724        1.22%
Vincent Sollitto, Jr.(8)...........................         85,999        1.19%
Howard M. Bailey(9)................................         84,167        1.16%
Barry L. Cox(10)...................................         21,458           *
Jeffrey Hawthorne(11)..............................         37,764           *
Carl J. Meurell(12)................................         23,955           *
Alan Nolet(13).....................................         65,669           *
William Pratt(14)..................................         13,198           *
Malcolm J. Thompson(15)............................         21,458           *
All executive officers and directors as a group (12
 persons)(16)......................................      1,875,572       24.53%
</TABLE>
- --------
*  Less than one percent.
(1) This table is based upon information supplied by officers, directors and
    principal shareholders and Schedules 13D and 13G, if any, filed with the
    Securities and Exchange Commission (the "SEC"). Unless otherwise indicated
    in the footnotes to this table and subject to community property laws
    where applicable, the Company believes that each of the shareholders named
    in this table has sole voting and investment power with respect to the
    shares indicated as beneficially owned. Applicable percentages are based
    on 7,157,169 shares outstanding on November 30, 1997, adjusted as required
    by rules promulgated by the SEC.
(2) Includes 439,167 shares held of record by Kleiner Perkins Caufield & Byers
    IV, L.P. ("KPCB") and 108,556 shares issuable upon the exercise of
    currently exercisable warrants held by KPCB; and 2,500 shares subject to
    stock options held by Mr. Kvamme exercisable within 60 days of the date of
    this table. Mr. Kvamme disclaims beneficial ownership of the shares held
    by KPCB except to his pecuniary interest therein.
(3) Consists of 534,375 shares held of record by LG Electronics Inc. and
    28,333 shares issuable upon the exercise of currently exercisable warrants
    held by LG Electronics Inc. Mr. Kim, a director of the Company, is an
    executive officer of LG Electronics Inc.
(4) Includes 108,556 shares issuable upon the exercise of currently
    exercisable warrants held by KPCB.
(5) Includes 6,062 shares issuable upon the exercise of currently exercisable
    warrants held by ML Venture Partners II, L.P.
 
                                      14
<PAGE>
 
(6)  Includes 31,912 shares subject to stock options held by Mr. Henley
     exercisable within 60 days of the date of this table.
(7)  Consists of 70,556 shares held of record by U.S. Venture Partners III;
     11,549 shares held of record by Second Ventures Partners, L.P.; 828 shares
     held of record by U.S.V. Entrepreneur Partners; and 4,791 shares subject
     to stock options held by Mr. Krausz exercisable within 60 days of the date
     of this table.
(8)  Includes 75,999 shares subject to stock options held by Mr. Sollitto
     exercisable within 60 days of the date of this table.
(9)  Includes 72,500 shares subject to stock options held by Mr. Bailey
     exercisable within 60 days of the date of this table.
(10) Includes 5,591 shares subject to stock options held by Mr. Cox
     exercisable within 60 days of the date of this table.
(11) Consists of 37,764 shares subject to stock options held by Mr. Hawthorne
     exercisable within 60 days of the date of this table.
(12) Includes 23,520 shares subject to stock options held by Mr. Meurell
     exercisable within 60 days of the date of this table.
(13) Includes 64,191 shares subject to stock options held by Mr. Nolet
     exercisable within 60 days of the date of this table.
(14) Includes 12,600 shares subject to stock options held by Mr. Pratt
     exercisable within 60 days of the date of this table.
(15) Includes 21,458 shares subject to stock options held by Dr. Thompson
     exercisable within 60 days of the date of this table.
(16) Includes shares described in the notes above, as applicable. Includes
     shares which certain executive officers, directors and principal
     shareholders of the Company have the right to acquire within 60 days
     after the date of this table pursuant to outstanding options and
     warrants.
 
SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
 
  Section 16(a) of the Securities Exchange Act of 1934 (the "1934 Act")
requires the Company's directors and executive officers, and persons who own
more than ten percent of a registered class of the Company's equity
securities, to file with the SEC initial reports of ownership and reports of
changes in ownership of Common Stock and other equity securities of the
Company. Officers, directors and greater than ten percent shareholders are
required by SEC regulation to furnish the Company with copies of all Section
16(a) forms they file.
 
  To the Company's knowledge, based solely on a review of the copies of such
reports furnished to the Company and written representations that no other
reports were required, during the fiscal year ended September 30, 1997, all
Section 16(a) filing requirements applicable to its officers, directors and
greater than ten percent beneficial owners were complied with, except that one
report covering one transaction was filed late by Mr. Barry L. Cox.
 
                            EXECUTIVE COMPENSATION
 
COMPENSATION OF DIRECTORS
 
  Each Non-Employee Director of the Company receives a per meeting fee of
$1,000 plus $500 for each committee meeting attended by the committee member.
In the fiscal year ended September 30, 1997, the total compensation paid to
Non-Employee Directors was $19,000. The members of the Board of Directors are
also eligible for reimbursement for their expenses incurred in connection with
attendance at Board meetings in accordance with Company policy.
 
  During the last fiscal year, the Company granted options covering 2,500
shares to each of Messrs. Cox, Krausz and Thompson at an exercise price per
share of $8.438. The fair market value of such Common Stock on the date of
grant was $8.438 per share (based on the closing sales price reported in the
Nasdaq National Market
 
                                      15
<PAGE>
 
System for the date of grant). As of November 30, 1997, options to purchase
15,867 shares of Common Stock at an exercise price of $5.375 per share had
been exercised by Non-Employee Directors.
 
                      COMPENSATION OF EXECUTIVE OFFICERS
                            SUMMARY OF COMPENSATION
 
  The following table shows for the fiscal years ended September 30, 1995,
1996 and 1997, compensation awarded or paid to, or earned by, the Company's
Chief Executive Officer and its other four most highly compensated executive
officers at September 30, 1997 (the "Named Executive Officers"):
 
                          SUMMARY COMPENSATION TABLE
 
<TABLE>
<CAPTION>
                                        ANNUAL              OTHER
                                     COMPENSATION           ANNUAL    SECURITIES
                               ------------------------- COMPENSATION UNDERLYING
 NAME AND PRINCIPAL POSITION   YEAR SALARY ($) BONUS ($)     ($)      OPTIONS (#)
 ---------------------------   ---- ---------- --------- ------------ -----------
 <S>                           <C>  <C>        <C>       <C>          <C>
 Vincent Sollitto, Jr........  1997  $225,900   $50,000        --          --
  Chief Executive Officer      1996    64,048       --         --       81,727
                               1995       --        --         --          --

 Howard M. Bailey............  1997   155,693    54,000        --          --
  Chief Financial              1996   150,503    49,875        --       38,700
  Officer and Secretary        1995   122,326       --         --       83,334

 Carl J. Meurell.............  1997   144,679    29,500     32,639(1)   12,000
  Vice President,              1996       --        --         --       37,876
  Sales and Marketing          1995       --        --         --          --

 Alan Nolet(2)...............  1997   140,338       --      56,870(1)      --
  Vice President               1996   279,644     4,000        --       51,910
  Worldwide Sales              1995   259,470       --         --       10,000

 William Pratt...............  1997   133,024    44,600        --       40,000
  Chief Technical              1996       --        --         --          --
  Officer                      1995       --        --         --          --
</TABLE>
- --------
(1) Represents commissions earned.
(2) Mr. Nolet resigned as Vice President, Worldwide Sales as of September 30,
    1997.
 
                                      16
<PAGE>
 
                              STOCK OPTION GRANTS
 
  The Company grants options to its executive officers under the Option Plan.
As of November 30, 1997, options to purchase a total of 690,172 shares were
outstanding under the Option Plan and options to purchase 116,986 shares
remained available for grant thereunder.
 
  The following tables show for the fiscal year ended September 30, 1997,
certain information regarding options granted to, and held at year-end by, the
Named Executive Officers:
 
                       OPTION GRANTS IN LAST FISCAL YEAR
 
<TABLE>
<CAPTION>
                                 INDIVIDUAL GRANTS
                         ---------------------------------
                          NUMBER OF
                         SECURITIES   % OF TOTAL OPTIONS
                          UNDERLYING  GRANTED TO EMPLOYEES
                           OPTIONS             IN          EXERCISE OR BASE PRICE EXPIRATION
NAME                     GRANTED (#)      FISCAL YEAR              ($/SH)            DATE
- ----                     ----------- --------------------- ---------------------- ----------
<S>                      <C>         <C>                   <C>                    <C>
Mr. Sollitto, Jr. ......      --              --                      --                --
Mr. Bailey..............      --              --                      --                --
Mr. Meurell.............   12,000             5.0%                 $6.750           5/20/07
Mr. Nolet...............      --              --                      --                --
Mr. Pratt...............   40,000            16.7%                 $5.875           10/3/06
                           10,000             4.2%                 $5.063          10/26/07
</TABLE>
 
                             EMPLOYMENT AGREEMENTS
 
  Each of Messrs. Sollitto, Bailey and Hawthorne is party to an agreement
which provides certain severance and other benefits in the event of a
termination of such person's employment with the Company following a change of
control of the Company. In the event termination of such officer's employment
(other than a voluntary termination by the officer or a termination for cause)
that occurs within up to fifteen months of a change in control of the Company,
the officer is entitled to between six months and fifteen months of severance
payments and benefits depending upon the timing of such termination and the
officer's obtaining alternative employment following termination. Upon such
change of control, each officer's options under the Option Plan become fully
exercisable if his employment is to terminate as of the closing of the change
of control. If such officer's employment with the Company is to continue
following a change of control, vesting of his options is accelerated by two
years as of the closing of the change of control. Under these agreements,
severance benefits consist of a continuation of the officer's base salary and
non-discretionary bonuses, if any, during the applicable severance period and
of his medical, health and other insurance benefits.
 
                             CERTAIN TRANSACTIONS
 
  At September 30, 1997, the Company had a loan outstanding in the principal
amount of $72,520 to Francois J. Henley, an executive officer of the Company.
Such loan was entered into in June 1995 for the purpose of exercising options
to purchase Common Stock of the Company. Such loan is evidenced by a full
recourse promissory note secured by shares of the Company's Common Stock and
is due on June 1, 2000. The interest rate on such loan is 6.83%, compounded
semiannually. Since the commencement of fiscal 1997, the largest aggregate
indebtedness of Mr. Henley under such loan was $94,456.31, including principal
and accrued interest.
 
  On October 10, 1996, Vincent Sollitto, Jr., Chief Executive Officer and a
director of the Company, issued a full recourse promissory note to the Company
in the amount of $56,253 at an interest rate of 6.72%, compounded annually,
for the purpose of purchasing Common Stock of the Company. Under the terms of
the promissory note,
 
                                      17
<PAGE>
 
principal and accrued but unpaid interest were payable in installments in the
amount of ten percent (10%) of Mr. Sollitto's salary on the first day of each
month beginning on November 1, 1996. All principal and accrued interest under
the promissory note was paid to the Company by Mr. Sollitto on October 10,
1997.
 
  The Company has entered into indemnity agreements with certain officers and
directors which provide, among other things, that the Company will indemnify
such officer or director, under the circumstances and to the extent provided
for therein, for expenses, damages, judgments, fines and settlements he may be
required to pay in actions or proceedings which he is or may be made a party
be reason of his position as a director, officer or other agent of the
Company, and otherwise to the full extent permitted under California law and
the Company's Bylaws.
 
                                 OTHER MATTERS
 
  The Board of Directors knows of no other matters that will be presented for
consideration at the Annual Meeting. If any other matters are properly brought
before the meeting, it is the intention of the persons named in the
accompanying proxy to vote on such matters in accordance with their best
judgment.
 
                                          By Order of the Board of Directors
 
                                          
                                          /s/ Howard M. Bailey
 
                                          Howard M. Bailey
                                          Chief Financial Officer
 
December 31, 1997
 
  A COPY OF THE COMPANY'S ANNUAL REPORT TO THE SECURITIES AND EXCHANGE
COMMISSION ON FORM 10-K FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 1997 IS
AVAILABLE WITHOUT CHARGE UPON WRITTEN REQUEST TO: CORPORATE SECRETARY, PHOTON
DYNAMICS, INC., 6325 SAN IGNACIO AVENUE, SAN JOSE, CALIFORNIA 95119.
 
                                      18
<PAGE>
 
 
 
 
 
                                                                      1455-PS-98
<PAGE>
 
                                  DETACH HERE                              PRO F

                             PHOTON DYNAMICS, INC.

                   PROXY SOLICITED BY THE BOARD OF DIRECTORS
                    FOR THE ANNUAL MEETING OF SHAREHOLDERS
                        TO BE HELD ON JANUARY 27, 1998

        The undersigned hereby appoints Vincent Sollitto, Jr. and Howard M. 
Bailey and each of them, as attorneys and proxies of the undersigned, with full 
power of substitution, to vote all of the shares of stock of Photon Dynamics, 
Inc. which the undersigned may be entitled to vote at the Annual Meeting of 
Shareholders of Photon Dynamics, Inc. to be held at the principal executive 
offices of Photon Dynamics, Inc. at 6325 San Ignacio Avenue, San Jose, 
California 95119 on Tuesday, January 27, 1998 at 2:00 p.m., local time, and at 
any and all postponements, continuations and adjournments thereof, with all
powers that the undersigned would possess if personally present, upon and in
respect of the following matters and in accordance with the following
instructions, with discretionary authority as to any and all other matters that
may properly come before the meeting.

        UNLESS A CONTRARY DIRECTION IS INDICATED, THIS PROXY WILL BE VOTED FOR 
ALL NOMINEES LISTED IN PROPOSAL 1 AND FOR PROPOSALS 2, 3 AND 4, AS MORE 
SPECIFICALLY DESCRIBED IN THE PROXY STATEMENT. IF SPECIFIC INSTRUCTIONS ARE 
INDICATED, THIS PROXY WILL BE VOTED IN ACCORDANCE THEREWITH.

                  CONTINUED AND TO BE SIGNED ON REVERSE SIDE         SEE REVERSE
                                                                         SIDE
<PAGE>
 
                                  DETACH HERE                              PRO F

[X] Please mark
    votes as in
    this example.

MANAGEMENT RECOMMENDS A VOTE FOR THE NOMINEES FOR DIRECTOR LISTED BELOW AND A 
VOTE FOR PROPOSALS 2, 3 AND 4.

1. To elect directors, whether by cumulative voting or otherwise, to hold office
   until the next Annual Meeting of Shareholders and until their successors are
   elected.

   NOMINEES: Vincent Sollitto, Jr., Francois J. Henley, E. Floyd Kvamme, Barry 
             L. Cox, Michael J. Kim, Steven M. Krausz and Malcolm J. Thompson.

             FOR  WITHHELD                                MARK HERE [_] 
             [_]    [_]                                 IF YOU PLAN   
                                                          TO ATTEND   
                                                        THE MEETING     
                                                                      
                                                          MARK HERE [_] 
                                                        FOR ADDRESS   
[_] ______________________________________               CHANGE AND   
    For all nominees except as noted above               NOTE BELOW     

                                                 
2. To approve the Company's 1995 Stock Option    FOR  AGAINST  ABSTAIN
   Plan, as amended to increase the              [_]    [_]      [_]   
   aggregate number of shares of Common Stock
   authorized for issuance under such plan by 
   300,000 shares.

3. To approve the Company's 1995 Employee        FOR  AGAINST  ABSTAIN
   Stock Purchase Plan, as amended to increase   [_]    [_]      [_]   
   the aggregate number of shares of Common 
   Stock authorized for issuance under such plan
   by 100,000 shares.

4. To ratify selection of Ernst & Young LLP as   FOR  AGAINST  ABSTAIN
   independent auditors of the Company for its   [_]    [_]      [_]   
   fiscal year ending September 30, 1998.    

PLEASE VOTE, DATE AND PROMPTLY RETURN THIS PROXY IN THE ENCLOSED RETURN ENVELOPE
WHICH IS POSTAGE PREPAID IF MAILED IN THE UNITED STATES.

Please sign exactly as your name appears hereon. If the stock is registered in
the names of two or more persons, each should sign. Executors, administrators,
trustees, guardians and attorneys-in-fact should add their titles. If signer is
a corporation, please give full corporate name and have a duly authorized
officer sign, stating title. If signer is a partnership, please sign in
partnership name by authorized person.



Signature:              Date:           Signature:              Date:
          -------------       ---------           -------------       ---------


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission